This company has been marked as potentially delisted and may not be actively trading. Medicis Pharmaceutical (MRX) Stock Forecast & Price Target Add Compare Share Share Analyst Forecasts Stock AnalysisAnalyst ForecastsCompetitorsDividendEarningsHeadlinesOptions ChainOwnershipTrendsBuy This Stock Get the Latest News and Ratings for MRX and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Medicis Pharmaceutical and its competitors. Enter your email to sign up for newsletter Sign Up MRX Analyst Ratings Over TimeTypeCurrent Forecast4/3/24 to 4/3/251 Month Ago3/4/24 to 3/4/253 Months Ago1/4/24 to 1/3/251 Year Ago4/4/23 to 4/3/24Strong Buy0 Strong Buy rating(s)1 Strong Buy rating(s)1 Strong Buy rating(s) N/A Buy7 Buy rating(s)8 Buy rating(s)8 Buy rating(s) N/A Hold2 Hold rating(s)0 Hold rating(s)0 Hold rating(s) N/A Sell0 Sell rating(s)0 Sell rating(s)0 Sell rating(s) N/A Consensus Price Target$35.00$33.25$31.75N/AForecasted Upside-8.71% Downside-5.63% Downside-2.37% DownsideN/AConsensus RatingModerate BuyBuyBuyN/A Remove Ads MRX Analyst Recommendations By MonthAnalyst Ratings Chart DescriptionThe chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.Skip Chart & View Analyst Rating History MRX Price Targets by MonthAverage Share Price and Price Target by Month Chart DescriptionThe chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table Medicis Pharmaceutical Stock vs. The CompetitionTypeMedicis PharmaceuticalFinance CompaniesS&P 500Consensus Rating Score 2.78 2.53 2.54Consensus RatingModerate BuyModerate BuyModerate BuyPredicted Upside-8.71% Downside47.12% Upside17.77% UpsideNews Sentiment RatingNeutral NewsSee Recent MRX NewsPositive NewsPositive News Remove Ads Recent Analyst Forecasts and Stock Ratings All Ratings Strong Buy Buy Hold Sell Rating Show All Upside > 100% Upside 50% - 100% Upside 20% - 50% Upside 10% - 20% Upside 0% - 10% Downside 0% - 10% Downside 10% - 20% Downside 20% - 50% Downside 50% - 100% Downside > 100% Upside/Downside All Actions Upgrades Downgrades Initiates Coverage Raises Target Lowers Target Reiterates Rating Action Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Years 5 Years Time Frame Start Date End Date Most Recent from Each Brokerage All Show Export to Excel DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails3/10/2025Hsbc Global Res0 of 5 starsC. Gomez-LopezSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold3/10/2025HSBC2 of 5 stars DowngradeBuy ➝ Hold$33.00 ➝ $36.00-1.32%3/7/2025The Goldman Sachs Group3 of 5 starsAlexander BlosteinSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost TargetBuy ➝ Buy$36.00 ➝ $40.00+14.58%3/7/2025BarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingBenjamin BudishSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost TargetOverweight ➝ Overweight$39.00 ➝ $43.00+18.59%1/7/2025Piper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy rating Boost TargetOverweight ➝ Overweight$32.00 ➝ $40.00+23.00%12/20/2024Keefe, Bruyette & WoodsSubscribe to MarketBeat All Access for the recommendation accuracy rating Boost TargetOutperform ➝ Outperform$33.00 ➝ $36.00+25.00%11/6/2024CitigroupSubscribe to MarketBeat All Access for the recommendation accuracy rating Reiterated RatingBuy ➝ Buy$34.00+24.77%5/20/2024UBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy rating Initiated CoverageBuy$27.00+41.51%5/20/2024Jefferies Financial GroupSubscribe to MarketBeat All Access for the recommendation accuracy rating Initiated CoverageBuy$24.00+25.79%Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 01:17 AM ET. MRX Forecast - Frequently Asked Questions What is Medicis Pharmaceutical's forecast for 2025? According to the research reports of 9 Wall Street equities research analysts, the average twelve-month stock price forecast for Medicis Pharmaceutical is $35.00, with a high forecast of $43.00 and a low forecast of $24.00. Should I buy or sell Medicis Pharmaceutical stock right now? 9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Medicis Pharmaceutical in the last twelve months. There are currently 2 hold ratings and 7 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" MRX shares. Does Medicis Pharmaceutical's stock price have much downside? According to analysts, Medicis Pharmaceutical's stock has a predicted downside of -8.71% based on their 12-month stock forecasts. Has Medicis Pharmaceutical been downgraded by Wall Street analysts recently? Over the previous 90 days, Medicis Pharmaceutical's stock had 2 downgrades by analysts. What analysts cover Medicis Pharmaceutical? Medicis Pharmaceutical has been rated by research analysts at Barclays, Hsbc Global Res, HSBC, Piper Sandler, and The Goldman Sachs Group in the past 90 days. Do Wall Street analysts like Medicis Pharmaceutical more than its competitors? Analysts like Medicis Pharmaceutical more than other "finance" companies. The consensus rating score for Medicis Pharmaceutical is 2.78 while the average consensus rating score for "finance" companies is 2.53. Learn more on how MRX compares to other companies. Stock Forecasts and Research Tools Related Companies BGC Group Stock Forecast StoneX Group Stock Forecast Forge Global Stock Forecast Intercontinental Exchange Stock Forecast CME Group Stock Forecast Nasdaq Stock Forecast Tradeweb Markets Stock Forecast LPL Financial Stock Forecast Cboe Global Markets Stock Forecast T. Rowe Price Group Stock Forecast Today's Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter This page (NYSE:MRX) was last updated on 4/3/2025 by MarketBeat.com Staff From Our PartnersTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredDOGE tax surpriseElon Musk's DOGE agents have some very strange plans for the IRS... Recently, it emerged that our tax auth...Altimetry | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredRetirement Nightmare? It’s Already Happening.The market is on edge. Every day, another company slashes its dividend, leaving investors scrambling. Intel...Investors Alley | SponsoredCaught on Camera: Elon Musk’s “Area 51”You won’t believe what tech legend Jeff Brown found in what he calls Elon Musk’s “Area 51.” (Click here to see...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medicis Pharmaceutical Corp Please log in to your account or sign up in order to add this asset to your watchlist. Share Medicis Pharmaceutical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy MRX Stock Free MRX Stock Alerts